PL1678189T3 - Sposób wytwarzania soli i pochodnych trans-lub cis-diamoniodichlorodihydroksoplatyny(IV) i ich zastosowanie do wytwarzania farmaceutycznych substancji aktywnych - Google Patents
Sposób wytwarzania soli i pochodnych trans-lub cis-diamoniodichlorodihydroksoplatyny(IV) i ich zastosowanie do wytwarzania farmaceutycznych substancji aktywnychInfo
- Publication number
- PL1678189T3 PL1678189T3 PL04789998T PL04789998T PL1678189T3 PL 1678189 T3 PL1678189 T3 PL 1678189T3 PL 04789998 T PL04789998 T PL 04789998T PL 04789998 T PL04789998 T PL 04789998T PL 1678189 T3 PL1678189 T3 PL 1678189T3
- Authority
- PL
- Poland
- Prior art keywords
- cis
- trans
- derivatives
- preparation
- salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000008065 acid anhydrides Chemical class 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03090344A EP1524273B1 (de) | 2003-10-13 | 2003-10-13 | Verfahren zur Herstellung von trans- oder cis-Diammoniumdichlorodihydroxoplatin (IV)-Salzen und -Derivaten und ihre Verwendung zur Herstellung von pharmazeutischen Wirkstoffen |
| US51209703P | 2003-10-20 | 2003-10-20 | |
| EP04789998A EP1678189B1 (de) | 2003-10-13 | 2004-10-13 | Verfahren zur herstellung von trans- oder cis-diammoniumdichlorodihydroxoplatin (iv)-salzen und -derivaten und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen |
| PCT/DE2004/002296 WO2005040045A2 (de) | 2003-10-13 | 2004-10-13 | Verfahren zur herstellung von trans- oder cis-diammoniumdichlorodihydroxoplatin (iv) -salzen und -derivaten und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1678189T3 true PL1678189T3 (pl) | 2007-08-31 |
Family
ID=34354539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04789998T PL1678189T3 (pl) | 2003-10-13 | 2004-10-13 | Sposób wytwarzania soli i pochodnych trans-lub cis-diamoniodichlorodihydroksoplatyny(IV) i ich zastosowanie do wytwarzania farmaceutycznych substancji aktywnych |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7687651B2 (pl) |
| EP (2) | EP1524273B1 (pl) |
| JP (1) | JP4887153B2 (pl) |
| CN (1) | CN100526324C (pl) |
| AT (2) | ATE346076T1 (pl) |
| AU (1) | AU2004283125B2 (pl) |
| BR (1) | BRPI0415295A (pl) |
| CA (1) | CA2565096C (pl) |
| DE (3) | DE50305768D1 (pl) |
| DK (1) | DK1678189T3 (pl) |
| ES (1) | ES2284061T3 (pl) |
| MX (1) | MXPA06003843A (pl) |
| PL (1) | PL1678189T3 (pl) |
| RU (1) | RU2345086C2 (pl) |
| UA (1) | UA85066C2 (pl) |
| WO (1) | WO2005040045A2 (pl) |
| ZA (1) | ZA200603018B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE347367T1 (de) * | 2003-10-13 | 2006-12-15 | Zoser B Salama | Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze |
| CZ2004964A3 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| WO2009156706A1 (en) * | 2008-06-27 | 2009-12-30 | University Of Strathclyde | Pulmonary drug delivery with vesicles comprising non-ionic surfactants |
| WO2014100417A1 (en) * | 2012-12-19 | 2014-06-26 | Blend Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| CN103043635B (zh) * | 2012-12-25 | 2015-04-22 | 浙江大学 | 一种抗耐药性的顺铂矿化液及其制备方法和应用 |
| WO2024023197A1 (en) * | 2022-07-29 | 2024-02-01 | King Faisal Specialist Hospital & Research Centre | Cisplatin analogue with potent anti-cancer and cancer stem cell-targeting effects and synthesis thereof |
| EP4311830B1 (en) * | 2022-07-29 | 2025-08-27 | King Faisal Specialist Hospital & Research Centre | Cisplatin analogue with potent anti-cancer effects and synthesis thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1585103A (en) * | 1976-04-06 | 1981-02-25 | Rustenburg Platinum Mines Ltd | Pharmaceutical compositions containing platinum compounds |
| GR75317B (pl) * | 1980-09-03 | 1984-07-13 | Johnson Matthey Plc | |
| SU1021116A1 (ru) | 1981-11-20 | 1996-11-20 | МГУ им. М.В.Ломоносова | Способ получения цис-диамминдихлородигидроксоплатины (iy) |
| SU1137698A1 (ru) * | 1983-10-17 | 1996-09-27 | МГУ им. М.В.Ломоносова | Способ получения цис-диамминдихлородигидроксоплатины (iy) |
| EP0328274B1 (en) * | 1988-02-02 | 1994-10-19 | Johnson Matthey, Inc., | Pt (IV) complexes |
| US5196555A (en) * | 1989-10-17 | 1993-03-23 | Bristol-Myers Squibb Company | Water and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activity |
| RU2086261C1 (ru) * | 1994-07-08 | 1997-08-10 | Химический факультет Московского государственного университета им.М.В.Ломоносова | Противоопухолевое средство |
| JPH10251285A (ja) * | 1997-03-14 | 1998-09-22 | Ss Pharmaceut Co Ltd | 白金（ｉｖ）錯体及びこれを含有する医薬 |
| ATE347367T1 (de) * | 2003-10-13 | 2006-12-15 | Zoser B Salama | Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze |
-
2003
- 2003-10-13 EP EP03090344A patent/EP1524273B1/de not_active Expired - Lifetime
- 2003-10-13 DE DE50305768T patent/DE50305768D1/de not_active Expired - Fee Related
- 2003-10-13 AT AT03090344T patent/ATE346076T1/de not_active IP Right Cessation
-
2004
- 2004-10-13 AU AU2004283125A patent/AU2004283125B2/en not_active Ceased
- 2004-10-13 DE DE502004003311T patent/DE502004003311D1/de not_active Expired - Lifetime
- 2004-10-13 CN CNB2004800298890A patent/CN100526324C/zh not_active Expired - Fee Related
- 2004-10-13 UA UAA200605216A patent/UA85066C2/ru unknown
- 2004-10-13 RU RU2006116314/04A patent/RU2345086C2/ru not_active IP Right Cessation
- 2004-10-13 ES ES04789998T patent/ES2284061T3/es not_active Expired - Lifetime
- 2004-10-13 WO PCT/DE2004/002296 patent/WO2005040045A2/de not_active Ceased
- 2004-10-13 US US10/595,400 patent/US7687651B2/en not_active Expired - Fee Related
- 2004-10-13 JP JP2006534580A patent/JP4887153B2/ja not_active Expired - Fee Related
- 2004-10-13 PL PL04789998T patent/PL1678189T3/pl unknown
- 2004-10-13 BR BRPI0415295-6A patent/BRPI0415295A/pt not_active IP Right Cessation
- 2004-10-13 DK DK04789998T patent/DK1678189T3/da active
- 2004-10-13 ZA ZA200603018A patent/ZA200603018B/en unknown
- 2004-10-13 EP EP04789998A patent/EP1678189B1/de not_active Expired - Lifetime
- 2004-10-13 MX MXPA06003843A patent/MXPA06003843A/es active IP Right Grant
- 2004-10-13 AT AT04789998T patent/ATE357451T1/de active
- 2004-10-13 CA CA2565096A patent/CA2565096C/en not_active Expired - Fee Related
- 2004-10-13 DE DE112004002485T patent/DE112004002485D2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1678189A2 (de) | 2006-07-12 |
| AU2004283125A1 (en) | 2005-05-06 |
| US20070286905A1 (en) | 2007-12-13 |
| ES2284061T3 (es) | 2007-11-01 |
| ATE346076T1 (de) | 2006-12-15 |
| EP1524273B1 (de) | 2006-11-22 |
| CA2565096A1 (en) | 2005-05-06 |
| UA85066C2 (ru) | 2008-12-25 |
| ATE357451T1 (de) | 2007-04-15 |
| JP4887153B2 (ja) | 2012-02-29 |
| RU2006116314A (ru) | 2007-11-20 |
| HK1097848A1 (en) | 2007-07-06 |
| ZA200603018B (en) | 2007-07-25 |
| WO2005040045A3 (de) | 2005-07-07 |
| AU2004283125B2 (en) | 2009-06-25 |
| WO2005040045A2 (de) | 2005-05-06 |
| DE112004002485D2 (de) | 2006-08-24 |
| DE50305768D1 (de) | 2007-01-04 |
| DE502004003311D1 (de) | 2007-05-03 |
| EP1524273A1 (de) | 2005-04-20 |
| RU2345086C2 (ru) | 2009-01-27 |
| CN1867573A (zh) | 2006-11-22 |
| JP2007513066A (ja) | 2007-05-24 |
| CN100526324C (zh) | 2009-08-12 |
| US7687651B2 (en) | 2010-03-30 |
| BRPI0415295A (pt) | 2006-12-26 |
| DK1678189T3 (da) | 2007-06-11 |
| EP1678189B1 (de) | 2007-03-21 |
| MXPA06003843A (es) | 2007-02-02 |
| CA2565096C (en) | 2011-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yıldırım et al. | N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II | |
| Niles et al. | Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation | |
| US20100152288A1 (en) | NOVEL a-LIPOIC ACID DERIVATIVES AND APPLICATIONS THEREOF | |
| Innocenti et al. | Nanoscale enzyme inhibitors: Fullerenes inhibit carbonic anhydrase by occluding the active site entrance | |
| EP0836597A1 (en) | N-substituted piperazine nonoates | |
| Angeli et al. | Activation studies with amines and amino acids of the β-carbonic anhydrase from the pathogenic protozoan Leishmania donovani chagasi | |
| PL1678189T3 (pl) | Sposób wytwarzania soli i pochodnych trans-lub cis-diamoniodichlorodihydroksoplatyny(IV) i ich zastosowanie do wytwarzania farmaceutycznych substancji aktywnych | |
| WO2000051686A1 (en) | Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia | |
| EP4072537A1 (en) | Cystine diamide analogs for cystinuria | |
| EP3989967B1 (en) | Compounds, compositions, and methods for protein degradation | |
| CN102665726A (zh) | 抗癌剂 | |
| EA026192B1 (ru) | Комплексные соединения железа(iii) для лечения и профилактики симптомов железодефицита и железодефицитной анемии | |
| CN109851592B (zh) | 奥利司他衍生物 | |
| HUP0001727A2 (hu) | Új 1-aza-2-alkil-6-aril-cikloalkán-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények | |
| US3769436A (en) | Compositions and methods for the treatment of hyperlipemia | |
| JP7838812B2 (ja) | 四核化配位子、核酸切断剤、抗がん剤又は四核金属錯体 | |
| CN102665727A (zh) | 抗癌剂 | |
| US3445478A (en) | Method of synthesizing adrenochrome monoaminoguanidine | |
| MY139236A (en) | 4-trifluoromethoxyphenoxybenzene-4' -sulfonic acids, process for their preparation and use in medicaments | |
| WO2002067866A2 (en) | Piperazine derivatives as metalloprotease inhibitors | |
| LANZI et al. | Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action. | |
| JPH0466567A (ja) | グルタチオン誘導体およびこれを有効成分とする医薬 | |
| EP2340020A1 (en) | Manganese and cobalt complexes, their preparation and use | |
| US20040214884A1 (en) | Method for supplementing magnesium in an animal | |
| EP0202854A2 (en) | Phosphine gold compounds |